drugset / Trial / NCT00140920

A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)

NCT00140920

Phase 4 Terminated 11 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to compare pre-operative administration of rofecoxib versus post-operative administration of diclofenac or rofecoxib, respectively, in the treatment of post-operative pain after total knee joint replacement in patients with osteoarthritis of the knee.

Timeline

Start
2004-05-25
Primary completion
2004-09-27
Completion
2004-09-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 75 mg
Subject rofecoxib Small molecule

Indications

No indication recorded.